Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Microorganisms ; 10(5)2022 May 18.
Article in English | MEDLINE | ID: mdl-35630487

ABSTRACT

The gut microbiota composition is important for nutrient metabolism, mucosal barrier function, immunomodulation, and defense against pathogens. Alterations in the gut microbiome can disturb the gut ecosystem. These changes may lead to the loss of beneficial bacteria or an increase in potentially pathogenic bacteria. Furthermore, these have been shown to contribute to the pathophysiology of gastrointestinal and extra-intestinal diseases. Pathologies of the liver, such as non-alcoholic liver disease, alcoholic liver disease, cirrhosis, hepatocellular carcinoma, autoimmune hepatitis, viral hepatitis, and primary sclerosing cholangitis have all been linked to changes in the gut microbiome composition. There is substantial evidence that links gut dysbiosis to the progression and complications of these pathologies. This review article aimed to describe the changes seen in the gut microbiome in liver diseases and the association between gut dysbiosis and liver disease, and finally, explore treatment options that may improve gut dysbiosis in patients with liver disease.

2.
Clin Transl Sci ; 13(1): 57-66, 2020 01.
Article in English | MEDLINE | ID: mdl-31343094

ABSTRACT

In the last decade, drug development has tackled substantial challenges to improve efficiency and facilitate access to innovative medicines. Integrated clinical protocols and the investigation of targeted oncology drugs in healthy volunteers (HVs) have emerged as modalities with an increase in scope and complexity of early clinical studies and first-in-human (FIH) studies in particular. However, limited work has been done to explore the impact of these two modalities, alone or in combination, on the scientific value and on the implementation of such articulated studies. We conducted an FIH study in HVs with an oncology targeted drug, an Mnk 1/2 small molecule inhibitor. In this article, we describe results, advantages, and limitations of an integrated clinical protocol with an oncology drug. We further discuss and indicate points to consider when designing and conducting similar scientifically and operationally demanding FIH studies.


Subject(s)
Antineoplastic Agents/adverse effects , Cardiovascular Diseases/diagnosis , Clinical Protocols , Protein Kinase Inhibitors/adverse effects , Research Design , Administration, Oral , Adult , Antineoplastic Agents/administration & dosage , Cardiovascular Diseases/chemically induced , Electrocardiography , Healthy Volunteers , Hematologic Neoplasms/drug therapy , Humans , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Male , Medical Oncology/methods , Middle Aged , Monitoring, Ambulatory/methods , Protein Kinase Inhibitors/administration & dosage , Protein Serine-Threonine Kinases/antagonists & inhibitors , Young Adult
3.
BMC Pregnancy Childbirth ; 14: 43, 2014 Jan 23.
Article in English | MEDLINE | ID: mdl-24450437

ABSTRACT

BACKGROUND: Understanding women's experiences and perspectives of antenatal care services is particularly critical for enhancing effectiveness of services delivery and addressing women's needs and expectations. As part of a comprehensive assessment of the maternity care services in Iraq, this study aimed to explore the views and experiences of antenatal care in a sample of women. METHODS: This explorative study was conducted in Erbil governorate, Iraq. Data were collected using Q methodology, a technique for eliciting subjective views and identifying shared patterns among individuals. A sample of 38 women of different educational and socioeconomic statuses were invited to sort a set of 39 statements reflecting different aspects of the available antenatal care services and issues related to their last pregnancies into a distribution on a scale of nine from "disagree most" to "agree most". By-person factor analysis was used to derive latent views through centroid factor extraction and varimax rotation of factors. RESULTS: Analysis of the participants' Q sorts resulted in identifying four distinct views and experiences of pregnancy and antenatal care services: (i) public maternity services second best: preference for, and ability to afford, private care, (ii) dissatisfaction with public maternity services: poor information sharing and lack of health promotion, (iii) satisfaction with public maternity service but information gaps perceived and (iv) public maternity services second best: preference for private care but unaffordable. The typical characterizations that were associated with each view were highlighted. CONCLUSIONS: This study revealed different patterns of views and experiences of women of pregnancy and antenatal care services and recognized the particular issues related to each pattern. Different patterns and types of problems and concerns related mainly to inadequate provision of information and poor interpersonal communication, poor utilization of public services and a general preference to use private services were identified in the different groups of women.


Subject(s)
Patient Outcome Assessment , Patient Satisfaction , Prenatal Care/standards , Private Sector/standards , Public Sector/standards , Adult , Attitude , Communication , Female , Health Promotion/standards , Humans , Iraq , Patient Education as Topic , Private Sector/economics , Public Sector/economics , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...